It was shown that ASCT2 is overexpressed in MM compared to healthy donors, sMM and MGUS, with highest expression in secondary plasma cell leukemia and MM cell lines representing aggressive end-stage disease, whereas the expression of SNAT5 and GLS1 was comparable in MGUS, sMM and MM [104]. This evidence concerns the gene SLC38A5 and Miyoshi myopathy.